Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Dhaun N, Strachan FE, Newby DE, et al.: Vasodilator effects of the endothelin ET receptor selective antagonist BMS-193884 in healthy men. Br J Clin Pharmacol 2005, 60:611–622.
2. Battistini B, Berthiaume N, Kelland N, et al.: Profile of past and current clinical trials involving endothelin receptor antagonists: the novel “-sentan” class of drug. Exp Biol Med (Maywood) 2006, 231:653–695.
3. Fryer RM, Rakestraw PA, Banfor PN, et al.: Blood pressure regulation by ETA and ETB receptors in conscious, telemetry-instrumented mice and role of ETA in hypertension produced by selective ETB blockade. Am J Physiol Heart Circ Physiol 2006, 290:H2554–H2559.
4. Ohkita M, Wang Y, Nguyen ND, et al.: Extrarenal ETB plays a significant role in controlling cardiovascular responses to high dietary sodium in rats. Hypertension 2005, 45:940–946.
5. Quaschning T, Rebhan B, Wunderlich C, et al.: Endothelin B receptor-deficient mice develop endothelial dysfunction independently of salt loading. J Hypertens 2005, 23:979–985.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献